Uroplasty Receives New Patent for Implantable Neuromodulation System and Method

For Further Information:

Uroplasty, Inc.

EVC Group

David Kaysen, President and CEO, or

Doug Sherk (Investors)

Medi Jiwani, Vice President, CFO, and Treasurer,

415.896.6820

952.426.6140

Chris Gale (Media)

646.201.5431